Articles with "recurrent persistent" as a keyword



Photo from wikipedia

Handheld Reflectance Confocal Microscopy for the Detection of Recurrent Extramammary Paget Disease

Sign Up to like & get
recommendations!
Published in 2017 at "JAMA Dermatology"

DOI: 10.1001/jamadermatol.2017.0619

Abstract: Importance Extramammary Paget disease (EMPD) is commonly refractory to surgical and nonsurgical therapies. Identifying recurrent or persistent EMPD is challenging because the disease is multifocal, and multiple blind scouting biopsies are usually performed in this… read more here.

Keywords: microscopy; disease; reflectance confocal; handheld reflectance ... See more keywords
Photo from wikipedia

Reliable neck sonography of nodal thyroglobulin to diagnose recurrent/persistent disease from papillary thyroid carcinoma

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of Clinical Ultrasound"

DOI: 10.1002/jcu.23456

Abstract: This study evaluates the correlation between the sonographic features and the nodal fine‐needle aspiration thyroglobulin (FNA‐Tg) in papillary thyroid carcinoma (PTC) patients with the recurrent/persistent lymph node for the purpose of the reasonable selection of… read more here.

Keywords: recurrent persistent; thyroglobulin; thyroid carcinoma; papillary thyroid ... See more keywords
Photo from wikipedia

Bevacizumab for recurrent, persistent or advanced cervical cancer: reproducibility of GOG 240 study results in “real world” patients

Sign Up to like & get
recommendations!
Published in 2017 at "Clinical and Translational Oncology"

DOI: 10.1007/s12094-017-1808-x

Abstract: PurposeBevacizumab is the only therapeutic target approved for patients with persistent, recurrent or advanced cervical cancer from a phase III study that combined with chemotherapy; it proves a significant increase in overall survival. To retrospectively… read more here.

Keywords: treatment; cervical cancer; study; advanced cervical ... See more keywords
Photo from wikipedia

Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer.

Sign Up to like & get
recommendations!
Published in 2018 at "Brachytherapy"

DOI: 10.1016/j.brachy.2018.01.010

Abstract: PURPOSE Management of locally recurrent or persistent esophageal cancer (EC) after standard chemoradiation is challenging. This study updates our experience of treating medically inoperable EC patients with endoluminal high-dose-rate brachytherapy (EHDRBT) including the patients treated… read more here.

Keywords: esophageal cancer; locally recurrent; persistent esophageal; brachytherapy ... See more keywords
Photo by ddpmarshall from unsplash

Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study.

Sign Up to like & get
recommendations!
Published in 2018 at "Gynecologic oncology"

DOI: 10.1016/j.ygyno.2018.08.027

Abstract: PURPOSE Bevacizumab (BV) monotherapy leads to compensatory upregulation of multiple signaling pathways, resulting in mTOR activation. We evaluated combining BV and everolimus (EV), an mTOR kinase inhibitor, to circumvent BV-resistance in women with recurrent or… read more here.

Keywords: bevacizumab; fallopian tube; ovarian fallopian; persistent ovarian ... See more keywords
Photo from wikipedia

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Sign Up to like & get
recommendations!
Published in 2020 at "Gynecologic oncology"

DOI: 10.1016/j.ygyno.2020.12.025

Abstract: BACKGROUND EP0057 (formerly CRLX101) is an investigational nanoparticle-drug conjugate (NDC) of a cyclodextrin-based polymer backbone plus camptothecin, a topoisomerase-1 inhibitor. Prior studies showed efficacy in recurrent or persistent, epithelial ovarian, fallopian tube or primary peritoneal… read more here.

Keywords: phase; formerly crlx101; ep0057 formerly; paclitaxel ... See more keywords
Photo from wikipedia

ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma

Sign Up to like & get
recommendations!
Published in 2021 at "International Journal of Gynecological Cancer"

DOI: 10.1136/ijgc-2021-003144

Abstract: Background Uterine serous carcinoma is a distinct histologic subtype of endometrial cancer with an aggressive phenotype, poor prognosis, and limited therapeutic options. A previous proof-of-concept phase II trial of the Wee1 inhibitor adavosertib in uterine… read more here.

Keywords: persistent uterine; uterine serous; women recurrent; recurrent persistent ... See more keywords
Photo by jonathanborba from unsplash

A second ductoscopy procedure in patients with recurrent and persistent pathological nipple discharge

Sign Up to like & get
recommendations!
Published in 2023 at "Breast Care"

DOI: 10.1159/000530817

Abstract: Background: Most patients suffering from pathological nipple discharge (PND) undergo local surgical procedures because standard radiologic imaging often fails to reveal the cause. Ductoscopy is a minimally invasive endoscopic technique that enables direct intraductal visualization… read more here.

Keywords: second ductoscopy; procedure; ductoscopy procedure; ductoscopy ... See more keywords

The prognosis of patients with recurrent or persistent ovarian clear cell carcinoma: Results from a randomized phase III study (JGOG3017/GCIG).

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.15_suppl.5515

Abstract: 5515 Background: There are currently no concise data on prognosis in patients with recurrent or persistent clear cell carcinoma (CCC). The JGOG3017/GCIG was a randomized phase III trial to compare paclitaxel plus carboplatin (TC) to… read more here.

Keywords: pps patients; prognosis patients; recurrent persistent; patients recurrent ... See more keywords
Photo by ldxcreative from unsplash

The Impact of BMI Changes on the Incidence of Glomerular Hematuria in Korean Adults: A Retrospective Study Based on the NHIS-HEALS Cohort

Sign Up to like & get
recommendations!
Published in 2023 at "Biomedicines"

DOI: 10.3390/biomedicines11030989

Abstract: Obesity and recurrent hematuria are known risk factors for chronic kidney disease. However, there has been controversy on the association between obesity and glomerular hematuria. This study aimed to investigate the association between body mass… read more here.

Keywords: persistent hematuria; disease; hematuria; bmi ... See more keywords
Photo from wikipedia

Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Gynecologic Oncology"

DOI: 10.3802/jgo.2022.33.e55

Abstract: Background Poly (adenosine diphosphate)-ribose polymerase (PARP) inhibitors for tumors with homologous recombination deficiency (HRD), including pathogenic mutations in BRCA1/2, have been developed. Genomic analysis revealed that about 20% of uterine leiomyosarcoma (uLMS) have HRD, including… read more here.

Keywords: oncology; gynecologic malignancies; recurrent persistent; recombination deficiency ... See more keywords